SEATTLE, April 09, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Global Cervical Total Disc Replacement Devices Market was valued at US$ 1,105.1 million in 2019, and is expected ...

Centinel Spine's prodisc technology is now the only TDR solution in the U.S. approved for one- and two-level use in both the cervical and lumbar spine. A total of 480 subjects were enrolled in the IDE ...

Centinel Spine LLC announced it received investigational device approval from the FDA to begin a two-level clinical trial for its prodisc C anterior cervical total disc devices: prodisc C Vivo and ...

NEW YORK, June 1, 2022 /PRNewswire/ -- A multicenter, prospective, randomized controlled trial is designed to assess the effectiveness of three different disc replacement devices used for two-level ...

Please provide your email address to receive an email when new articles are posted on . After a review by its Medical Policy & Technology Assessment Committee, Anthem Blue Cross/Blue Shield updated ...

WEST CHESTER, Pa., April 12, 2023 /PRNewswire/ -- Centinel Spine ®, LLC, ("the Company") a leading global medical device company addressing cervical and lumbar spinal disease by providing the most ...

SECAUCUS, N.J., Sept. 26, 2019 /PRNewswire/ -- Dr. Fabien Bitan, Chief of Spine Surgery at Lenox Hill Hospital and a leading clinical researcher in the field of spinal arthroplasty, will perform the ...

Simplify® Cervical Artificial Disc achieved the highest overall clinical success rate at both one- and two-levels compared to any other approved cervical disc SAN DIEGO, April 6, 2021 /PRNewswire/ -- ...

WEST CHESTER, Pa., Oct. 14, 2025 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with ...